Links to scientific, peer reviewed, cannabis related research

[mjbarratt]

Growing medicine: Small-scale cannabis cultivation for medical purposes in six different countries

Hakkarainen 2014 IJDP In press.pdf

[mjbarratt]

The whole special issue on cannabis cultivation is now available at: http://www.sciencedirect.com/science/journal/09553959/26/3

 

Let me know if there is anything there you would like to access in full text!

[Matanuska Thunder]

Thank you Monica!

Please, If you wouldn't mind, I would like to read these:

 

• The globalisation of cannabis cultivation: A growing challenge
• Global patterns of domestic cannabis cultivation: Sample characteristics and patterns of growing across eleven countries
• Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model
• Four barriers and a set of values that prevent violence among cannabis growers 
• Representativeness of online purposive sampling with Australian cannabis cultivators

[teahaircut]

Cannabis, even extremely low doses more effective than any current drug on the market to treat and prevent the onset and development of Alzheimer's disease.  Eubanks study done in 2006, now a new one out August 2014, though I do not have access to the complete medical document.  Alzheimers... estimated. $21 billion in healthcare annually.  Go weed!

 

Eubanks.pdf

Conclusion We have demonstrated that THC competitively inhibits AChE and, furthermore, binds to the AChE PAS and diminishes Aâ aggregation. In contrast to previous studies aimed at utilizing cannabinoids in Alzheimer’s disease therapy, 8-10 our results provide a mechanism whereby the THC molecule can directly impact Alzheimer’s disease pathology. We note that while THC provides an interesting Alzheimer’s disease drug lead, it is a psychoactive compound with strong affinity for endogenous cannabinoid receptors. It is noteworthy that THC is a considerably more effective inhibitor of AChE-induced Aâ deposition than the approved drugs for Alzheimer’s disease treatment, donepezil and tacrine, which reduced Aâ aggregation by only 22% and 7%, respectively, at twice the concentration used in our studies. Therefore, AChE inhibitors such as THC and its analogues may provide an improved therapeutic for Alzheimer’s disease, augmenting acetylcholine levels by preventing neurotransmitter degradation and reducing Aâ aggregation, thereby simultaneously treating both the symptoms and progression of Alzheimer’s disease

 

August 2014 link: http://iospress.metapress.com/content/8421pvx80144t354/